Ingredient guides

GHK-Cu, the Copper Peptide: What It Is, What the Evidence Shows, and How It Is Sold

GHK-Cu is a copper-bound tripeptide (glycine-histidine-lysine) found in human plasma and used in cosmetic serums. Its human evidence is real but thin, and how it is formulated matters as much as the concentration on the label.

By the Peppies research desk · Published 8 September 2026 · Updated25 September 2026

Most people meet GHK-Cu as a blue serum with a confident label. It deserves a more careful introduction than that, because it is one of the few cosmetic peptides with a real biological backstory, a real (if thin) human evidence base, and a real set of ways to ruin it in a bottle.

What is GHK-Cu?

GHK is a tripeptide: glycine, histidine and lysine, in that order. In the body it circulates bound to a copper(II) ion, which is the “Cu” in GHK-Cu. It was found in 1973 by the biochemist Loren Pickart, who was chasing a factor in human plasma that made aged liver cells behave like young ones and eventually isolated this three-amino-acid fragment.

Two facts from that history explain most of what follows. First, it is endogenous: your plasma carries it now. The figure usually quoted is about 200 ng/mL at age 20 falling to about 80 ng/mL by 60 — a figure that comes from Pickart’s own work and has not been widely re-measured, so treat it as an estimate rather than a constant. Second, Pickart went on to found a company that sells copper-peptide skincare, and he co-authored the most-cited reviews. That does not make the science wrong; it does mean the enthusiastic summaries you will read online are, at one remove, the discoverer’s own.

In cosmetics the ingredient appears on the label under its INCI name, Copper Tripeptide-1.

What does the evidence on GHK-Cu actually show?

It helps to separate three layers, because they carry very different weight.

Cells and animals: strong signal. In culture, GHK-Cu increases collagen and elastin synthesis, glycosaminoglycan production and the balance of matrix-remodelling enzymes; in wounded animals it accelerates closure, granulation and blood-vessel growth. An analysis of the Broad Institute’s Connectivity Map data, reported in the Pickart reviews, found that GHK shifted the expression of roughly a third of human genes in cultured cells by 50 % or more, about six in ten of them upward. That breadth is striking and is also the thing to be cautious about: a molecule that moves thousands of genes in a dish is not thereby a treatment for anything.

Human skin, topical: promising but small. The human studies most often cited are these:

• Leyden and colleagues, 2002: a facial cream on 71 women and an eye cream on 41 women, twelve weeks each, with improvements in skin density, laxity and fine lines. These were presented as conference posters, not peer-reviewed papers.
• Abdulghani and colleagues, 1998: twelve weeks on thigh skin, with collagen production improving in 70 % of treated women, against 50 % for vitamin C and 40 % for retinoic acid in the same study.
• Finkley and colleagues, 2005: twelve weeks, twice daily, with improved laxity, clarity and fine lines, published as a book chapter.
• Badenhorst and colleagues, 2016: eight weeks of GHK-Cu in a lipid nano-carrier against Matrixyl 3000 and a control, reporting a 55.8 % reduction in wrinkle volume against control and 31.6 % against Matrixyl.

Read together, the human record is consistent in direction and consistently limited: small groups, twelve weeks or less, several company-run, and no large independent trial. The honest grade for “GHK-Cu improves the appearance of ageing facial skin” is promising, moderately supported. The grade for “GHK-Cu rebuilds collagen the way retinoids do” is not established. Peppies’ compendium uses the same grading vocabulary, so a B there means what it means here.

Beyond skin: not your concern in a serum. You will see claims about hair, lungs, nerves and “systemic rejuvenation”. Those come from animal and cell work and from routes of administration that have nothing to do with a topical cosmetic. A cosmetic-grade product is for skin. That is not a marketing restriction; it is the boundary of the evidence.

How much GHK-Cu do cosmetic products contain?

Concentration is the number the label rarely gives you, so here is the landscape.

Supplier formulation guidance places finished facial serums at roughly 0.1–0.3 % GHK-Cu, face creams at 0.05–0.1 %, and eye products lower still. Peppies’ own Glow Drops formulates Copper Tripeptide-1 at 0.05 %, fourth on the ingredient list and first among the actives. At the high end of the mass market, NIOD states 1 % GHK-Cu by weight alongside 1 % free GHK; The Ordinary’s “Copper Peptides 1 %” is a multi-peptide formula and does not disclose how much of the 1 % is GHK-Cu. Anything advertised above about 1 % is unusual, and nothing in the human studies above supports the idea that more is better — several used concentrations the sponsors never published.

Two practical consequences. A serum that lists Copper Tripeptide-1 near the end of its INCI, after preservatives, is decorative. And a serum that is not blue contains very little of it, because the copper complex is blue at any working concentration.

Why does a GHK-Cu serum turn green? Formulation traps

GHK-Cu’s usefulness depends on the copper staying bound to the peptide. Several ordinary skincare ingredients pull it off. The following figures come from a supplier’s technical guidance and are marked as such because they have not been independently published, but they agree with the chemistry.

• Acid. The copper is held by histidine and the peptide backbone, and that hold weakens as pH falls. Below roughly pH 3.5 free copper ions are released; a working range of pH 4–6 is recommended. This is why GHK-Cu and L-ascorbic acid (which sits around pH 3) are a poor pair in one bottle: the acid strips the copper, and free copper then catalyses the oxidation of the vitamin C. The same logic applies to AHA and BHA exfoliant formulas.
• Chelators. EDTA, common as a stabiliser, binds copper more strongly than GHK does (a formation constant around 10^18.8 against roughly 10^16–17 for GHK) and will simply take it. Phytic acid does the same. Check the INCI of a copper serum for disodium EDTA.
• Thiols. Ingredients with free sulphur–hydrogen groups form copper–sulphur bonds. Uncommon in serums, relevant in some hair products.
• Heat and light. In one stability series, 97 % of GHK-Cu remained after twelve weeks sealed and dark at 25 °C, against 52 % at 40 °C in ambient light. A blue serum on a sunny bathroom shelf is quietly losing its active.

The colour is your instrument. A correct GHK-Cu solution is clear blue to blue-violet. A shift to green or brown means copper has come free or oxidised; a fading blue means the complex is dissociating. Neither is dangerous; both mean the product is no longer what it was.

How does GHK-Cu differ from AHK-Cu, Matrixyl and Snap-8?

Cosmetic peptides get sold as a family. They are not; they work by unrelated mechanisms and carry unrelated evidence. Since these four sit side by side on Peppies’ cosmetic shelf, here is how to tell them apart.

GHK-Cu (Copper Tripeptide-1) — a signal peptide. Endogenous, copper-bound, acts by shifting the skin’s own remodelling programme. Evidence as above: strong in cells, promising and small in humans.

AHK-Cu (Copper Tripeptide-3) — the same copper-carrying idea with alanine in place of glycine, positioned for scalp and hair rather than face. The key study, Pyo and colleagues in 2007, cultured 240 human hair follicles from ten donors for twelve days and found follicle elongation and dermal-papilla cell proliferation at picomolar to nanomolar concentrations, with the effect reversing at higher doses. That is an ex vivo result. Independent human trials on scalps are thin, so the honest grade is plausible, not demonstrated.

Matrixyl (palmitoyl pentapeptide-4, pal-KTTKS) — a matrikine: a fragment of collagen that tells fibroblasts to make more. Its evidence is one of the better single studies in cosmetic peptides — Robinson and colleagues, 2005: 93 women aged 35–55, twelve weeks, double-blind, split-face, placebo-controlled, at 3 parts per million, with measurable improvement in fine lines. It was sponsored by Procter & Gamble, the effect was modest next to prescription retinoids, and it is a single centre. Note that “Matrixyl 3000” is a different blend of two other peptides; check which the label means.

Snap-8 (acetyl octapeptide-3) — a neurotransmitter-inhibitor peptide, an eight-amino-acid extension of Argireline that mimics part of the SNAP-25 protein and dampens the muscle signalling behind expression lines. Its in-vitro data (a reported 63 % reduction in vesicle release) is the manufacturer’s, and the human wrinkle-depth figures usually quoted for it come from studies of Argireline, not Snap-8. It is supplied as a dilute solution used at 3–10 % of a formula. Grade: mechanistically neat, independently unproven.

The practical reading: GHK-Cu and Matrixyl aim at structure and have some human support; Snap-8 aims at expression lines and has mostly borrowed evidence; AHK-Cu is a scalp bet with laboratory backing. Layering all four is a purchase decision, not an evidence-based one.

How do you recognise a good GHK-Cu product?

Whether you are buying a finished serum or a cosmetic-grade vial, the same questions apply.

Grade. “Cosmetic grade” means made and documented for topical use under cosmetic rules; “research grade” means made for laboratory work and documented for that. Neither is a purity statement on its own, and neither is licensed for injection. Cosmetic-grade GHK-Cu is for skin.

Form. Bulk GHK-Cu is a deep-blue crystalline powder that dissolves in water at around 10 mg/mL. Powder keeps for months refrigerated, dark and dry; suppliers hold long-term stock frozen. Solutions age far faster, which is why finished serums carry preservatives and why a home-mixed one has a short life.

That blue is worth knowing before a vial is ever opened, because colour is a property of the specific compound rather than a general rule: what a vial’s colour and cake can and cannot tell you sets out why most peptides are white, why GHK-Cu and a few others are not, and why appearance still settles nothing on its own.

The certificate, in one paragraph. A batch certificate of analysis for a cosmetic peptide should show identity by mass spectrometry (the copper complex is a distinct mass from free GHK), purity by HPLC (cosmetic and research grades commonly specify 95–99 %), the copper-to-peptide ratio or copper content, water content, and the counter-ion — and it should carry the batch number that is on your vial. The sterility and endotoxin tests that matter for injectables are not what a topical certificate is for. How to read those fields is covered in the COA guide, how to spot a recycled certificate in the red-flags guide, and how to check the lab that issued it in the lab-verification guide; the point here is only that the certificate should exist, match the batch, and be verifiable at the lab that issued it.

What do the EU rules say about GHK-Cu in cosmetics?

In the EU, Copper Tripeptide-1 is a listed cosmetic ingredient under Regulation (EC) 1223/2009 with no restriction in the annexes, and cosmetic products containing it must have a safety assessment and a product information file behind them. Decades of topical use have produced no pattern of serious adverse effects, which is consistent with a molecule the body already carries; the reviews’ phrase is “without any adverse effects”, and it is fair to read that as no signal found rather than proven harmless in all uses.

Practically: patch-test a new copper serum, expect a faint blue-green tint that washes off, stop if it stings, and keep it away from products that strip the copper (see above). It is a cosmetic; it supports the look and feel of skin and treats nothing. Anyone using it on broken skin, during pregnancy, or alongside prescribed dermatological treatment should ask a clinician, who beats any serum.

Sources

• Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci 2018;19(7):1987. doi:10.3390/ijms19071987 — the primary review; note the authors’ commercial interest.
• Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci 2005;27(3):155–160. doi:10.1111/j.1467-2494.2005.00261.x
• Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res 2007;30(7):834–839. doi:10.1007/BF02978833
• Leyden J et al. 2002 (conference posters), Abdulghani AA et al. 1998, Finkley MB et al. 2005, Badenhorst T et al. 2016 — as summarised in Pickart & Margolina 2018.
• Blanes-Mira C et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci 2002;24(5):303–310 — the Argireline evidence that Snap-8 marketing borrows.
• EU CosIng database entry for Copper Tripeptide-1; Regulation (EC) No 1223/2009 on cosmetic products.
• Supplier technical guidance on GHK-Cu pH range, chelator competition, stability and storage (industry source, not peer-reviewed; figures reproduced with that caveat).
• Peppies Glow Drops product page — actives map (Copper Tripeptide-1 at 0.05 %, LOT 0424).